(1)
HemoTypeSCTM Point-of-Care Testing As a Screening Tool for Sickle Cell Disease Among Newborns in Ilesa, Nigeria. Niger J Paediatr 2026, 53 (1), 20-27. https://doi.org/10.63270/njp.v53i1.2000045.